Indinavir and systemic hypertension

被引：45

作者：

Cattelan, AM ^{[1
]}

Trevenzoli, M

Sasset, L

Rinaldi, L

Balasso, V

Cadrobbi, P

机构：

[1] Gen Hosp Padua, Dept Infect Dis, Padua, Italy

[2] Res & Innovat, Padua, Italy

来源：

AIDS | 2001年 / 15卷 / 06期

关键词：

D O I：

10.1097/00002030-200104130-00021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：805 / 807

页数：3

共 6 条

[1]

[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005

[2] Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients [J].

Brodie, SB ;

Keller, MJ ;

Ewenstein, BM ;

Sax, PE .

AIDS, 1998, 12 (18) :2433-2437

[3] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[4] Hit HIV-1 hard, but only when necessary [J].

Harrington, M ;

Carpenter, CCJ .

LANCET, 2000, 355 (9221) :2147-2152

[5] Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].

Palella, FJ ;

Delaney, KM ;

Moorman, AC ;

Loveless, MO ;

Fuhrer, J ;

Satten, GA ;

Aschman, DJ ;

Holmberg, SD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860

[6] Indinavir nephropathy [J].

Tashima, KT ;

Horowitz, JD ;

Rosen, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (02) :138-140

← 1 →